Arvid Söderhäll
Company: Empros Pharma
Job title: Chief Executive Officer
Seminars:
How Sustainable is Drug-Based Management of Chronic Obesity & When Should Treatment Start? 11:45 am
Finite treatment beyond GLP-1 receptor agonists: establishing sustainable treatment of obesity Advancing a safer and more potent method to address the medical need of obese patients in combination with other treatments Navigating early intervention: when does it make sense to start treating patients?Read more
day: Day 2 Stream 2 AM
Panel Discussion: Obesity, Diabetes & NASH: What do Payers Need to See? 2:00 pm
Defining payer expectations and considering long term value Assessing higher risk patient populations and preventing comorbidities Harmonizing global patient metricsRead more
day: Day 1 Stream 2 PM